舒肝解郁胶囊联合黛力新治疗功能性胃肠病的临床疗效

雷雅莉，王亚婷 * ，王宇晖

渭南市中心医院消化内科，陕西 渭南，714000

浏览次数：390次 下载次数：258次

摘要：

目的 观察舒肝解郁胶囊联合黛力新治疗功能性胃肠病患者的临床疗效。方法 将 68例功能性胃肠病患者随机分为两组，每组 34例。对照组给予舒肝解郁胶囊，观察组在对照组基础上加用黛力新。比较两组患者的治疗效果、SAS和 SDS评分及不良反应发生情况。结果 观察组治疗总有效率明显高于对照组（P<0.05）；治疗后，两组的 SAS和 SDS评分均明显降低，且观察组的 SDS评分明显低于对照组（P<0.05）。结论 舒肝解郁胶囊联合黛力新治疗功能性胃肠病疗效显著，值得临床推广应用。

关键词： 功能性胃肠病；黛力新；舒肝解郁胶囊

中图分类号：R259文献标志码：A文章编号：2096-1413(2018)09-0028-02

Clinical efficacy of Shugan Jieyu capsule combined with deanxit in the treatment of
functional gastrointestinal disorders

LEIYa-li,W ANG Ya-ting * ,WANG Yu-hui
(Gastroenterology Department, Weinan CentralHospital,W einan 714000,China)




ABSTRACT: Objective To observe the clinical efficacy of Shugan Jieyu capsule combined with deanxit in patients with functional gastrointestinal disorders. Methods Sixty-eight patients with functional gastrointestinal disorders were randomly divided into two groups, with 34 cases in each group.The control group was treated with Shugan Jieyu capsule,the observation group added deanxiton the basis of the control group.The curative effect, SAS and SDS scores and the incidence of adverse reactions were compared between the two groups. Results The total effective rate of the observation group was significantly higher than that of the control group (P<0.05). After treatment,the scores of SAS and SDS in both groups significantly decreased,and the SDS score of the observation group was significantly lower than that of the control group (P<0.05). Conclusion Shugan Jieyu capsule combined withdeanxit in the treatment of functional gastrointestinal disorders has significantly clinical curative effect,which is worthy of clinical application.
KEYWORDS: functional gastrointestinal disorders; deanxit;Shugan Jieyu capsule

参考文献：
[1]MIW A H,GHOSHAL UC,FOCK KM,etal.Asian consensus reporton functional dyspepsia[J].JGestroenterolHepatol,2012,27(4):626-641.
[2] 中华医学会消化病学分会胃肠动力学组 . 我国消化不良的诊治流程和指南 [J]. 中华消化杂志 ,2000,20(7):264-265.
[3]ZAGARI RM ,LAW GR,FUCCIO L,etal.Epidemiology offunctionaldyspepsia and subgroupsin the Italian generalpopulation:an endoscopicstudy[J].Gastroenterology,2010,138(4):1302-1311.
[4] HORVATH A,DZIECHCIARZ P,SZAJEW SKA H.M eta-analysis:lactobacillus rhamnosus GG for abdominalpain-related functional gastrointestinal disorders in childhood[J].Aliment Pharmacol Ther,2011,33(12):1302-1310.
[5]VAN OUDENHOVE L,VANDENBERGHE J,VOS R,et al.Abusehistory,depression,and somatization are associated with gastric sensitivity and gastric emptying in functional dyspepsia[J].Psychosom Med,2011,73(8):648-655.
[6] FUJIW ARA Y,ARAKAW A T.Overlap in patients with dyspepsia/functionaldyspepsia[J].J Neurogas troenterolMotil,2014,20(4):447-457.
[7]MIRANDA A.Early life stress and pain:an importantlink to functional boweldisorders[J].PediatrAnn,2009,38(5):279-282.
[8] 郭秋霞,彭娜,吕飞,等.黛力新对功能性消化不良患者治疗后焦虑和抑郁的改善作用 [J]. 世界华人消化杂志 ,2015,23(4):324-327.